# Phase 1 Trial With SIR-Spheres and Cetuximab +/- Erlotinib

> **NCT01432119** · PHASE1 · WITHDRAWN · sponsor: **M.D. Anderson Cancer Center**

## Conditions studied

- Advanced Cancers

## Interventions

- **DEVICE:** SIR-Spheres
- **DRUG:** Cetuximab
- **DRUG:** Erlotinib
- **PROCEDURE:** Break-Through Scan

## Key facts

- **NCT ID:** NCT01432119
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-12
- **Primary completion:** 2019-12
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01432119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01432119, "Phase 1 Trial With SIR-Spheres and Cetuximab +/- Erlotinib". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01432119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*